Features
Pricing
Events
Reg.News
Short Interest
Explore Content
- Explore
  - Providers
    
    Providers
    
    Free/Commissioned
    
    High Net Worth Offering
    
    Institutional Offering
    
    Free/Commissioned
    
    Research that is free to access for all investors. Companies commission these providers to write research about them.
    View Research
    
    What is our Main Bundle Offering?
    
    Brokers who write research on their corporate clients and make it available through our main bundle offering.
    View Research
    
    What is Institutional?
    
    Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
    View Research
  - Regions
    
    Regions
    
    UK
    
    Rest of EMEA
    
    N America
    
    APAC
    
    LatAm
  - Exchanges
    
    Exchanges
    
    Aquis Apex
    
    Australian Securities Exchange
    
    Canadian Securities Exchange
    
    Euronext Paris
    
    London Stock Exchange (domestic)
    
    SIX Swiss Exchange
  - Sectors
    
    Sector Coverage
    
    Building & Construction
    
    Discretionary Personal Goods
    
    Discretionary Retail
    
    Energy
    
    Health
    
    Investment Trusts
    
    Media
    
    Resources
    
    Technology
  - Small / Large Cap
    
    Small / Large Cap
    
    UK100
    
    UK250
    
    UK Smallcap
    
    UK Other Main Markets
    
    Other
Login
Sign Up

LIVE

Event in Progress:

Join Here ×

04 Feb 2026

Hybridan Monthly - February Edition

RC Fornax plc (RCFX:LON), 12.8 | Quantum Base Holdings Plc (QUBE:LON), 24.0 | Ondine Biomedical, Inc. (OBI:LON), 8.5 | Shield Therapeutics Plc (STX:LON), 10.1 | First Tin Plc (1SN:LON), 0 | Conroy Gold & Natural Resources Plc (CGNR:LON), 15.8 | N4 Pharma Plc (N4P:LON), 0.5 | GETECH Group plc (GTC:LON), 2.0

- Jon Levinson | Hybridan Team
- 15 pages

Hybridan Monthly, 3 February 2026 Market Comment: By Niall Pearson For a special February 2026 edition of Hybridan’s View from the Broker’s Desk, we are delighted to be joined by Laurence Hulse, founder of Onward Opportunities, a leading UK Small Cap Investment Trust. Laurence started his career at Gresham House in 2015, around the time of its inception, and worked on a number of outperforming equity products. Recently, Onward Opportunities reported a record year of net asset value growth in the ....

Sign up to access

Get access to our full offering from over 100 providers

Get access to our full offering from over 100 providers

Already a member? Log in here

Hybridan Monthly - February Edition

RC Fornax plc (RCFX:LON), 12.8 | Quantum Base Holdings Plc (QUBE:LON), 24.0 | Ondine Biomedical, Inc. (OBI:LON), 8.5 | Shield Therapeutics Plc (STX:LON), 10.1 | First Tin Plc (1SN:LON), 0 | Conroy Gold & Natural Resources Plc (CGNR:LON), 15.8 | N4 Pharma Plc (N4P:LON), 0.5 | GETECH Group plc (GTC:LON), 2.0

Published: 04 Feb 2026
Author: Jon Levinson | Hybridan Team
Pages: 15

Hybridan Monthly, 3 February 2026 Market Comment: By Niall Pearson For a special February 2026 edition of Hybridan’s View from the Broker’s Desk, we are delighted to be joined by Laurence Hulse, founder of Onward Opportunities, a leading UK Small Cap Investment Trust. Laurence started his career at Gresham House in 2015, around the time of its inception, and worked on a number of outperforming equity products. Recently, Onward Opportunities reported a record year of net asset value growth in the ....

More Content

More Content

RC Fornax chair David Hitchcock talks board refresh, growth strategy & defence outlook

Companies: RC Fornax plc

Hardman & Co Healthcare Index: 2025 – Index rose, but another tough year

Companies: GSK FUM IMM AGY GDR HVO FAB VAL STX

RC Fornax chair David Hitchcock talks board refresh, growth strategy & defence outlook

Companies: RC Fornax plc

RC Fornax’s growth story: from defence review to record quarter - Part 3

Companies: RC Fornax plc

Hybridan Research: Conroy Gold & Natural Resources

Companies: Conroy Gold & Natural Resources Plc

Research Tree

Useful Links

Features
Pricing
RNS/Newswires Feeds
Providers Hub
Company Hub
Stock Pick League
iOS and Android Apps

Account

Login
Join Now
Contact

Follow us on Linkedin
Follow us on X

© Research Tree 2026

Terms of Service
Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top

Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Explore Content
Providers
Contact
Sign Up
Sign In